市况评论

作者

倪国权先生 (Alex Ni)
助理经理

曾任职钢材交易员及广告公司主任,所以特别喜欢研究资源类及消费类股票。欢迎来电赐教或交流心得。
电话:
22776779

现代牙科 (3600.HK)

2019年2月19日 星期二 观看次数2922

Stock Commentary                                                                                           Date: 18/2/2019

         

Stock:                                                     Modern Dental Group Limited

Closing price:                                      $1.46 (18/02/2019)

52 weeks range:                                         $1.20 - $2.53

Shares outstanding:                           990,277,000

Market Capitalization:                 HK$ 1.446 Billion

Target Price (12 months):                          No Target (initial coverage)

 

Summary :

This is an initial coverage of Modern Dental Group Limited. The company is dental prosthetic device provider and operates their businesses in various cities across the globe. They have three product lines: Fixed Prosthetic devices, Removable Prosthetic devices and Other Devices such as orthodontic devices, sports guards and anti-snoring devices etc. Fixed Prosthetic device is the main source of revenue of the company and currently, Europe and North America are major markets in contributing the company’s income, while Asian market segment continue to increase due to demand rising demand of dental healthcare.

 

Brief Look of the Company :

  1. Modern Dental Group Limited (the Company) is a global dental prosthetic device provider. Its businesses are across the globe. Listed on the Hong Kong Stock exchange in December 2015, the Company raised approximately HKD 664 million and the fund was used mainly to develop new businesses in oversea and acquire target firms.

The chart below illustrates the Company’s worldwide subsidiaries:

 

Source: Modern Dental 2018 interim report

 

In terms of revenue, both Europe and North America market contributed over 70% of the Company’s revenue in 2018, while Greater China market exhibited the largest growth rate in comparison with other markets. The table below explained the breakdown based on each market in their respective original currency against Hong Kong Dollar:

Source: Modern Dental 2018 interim report

 

  1. There are three main product lines (as categorized by the Company):
  1. Fixed Prosthetic devices such as crowns and bridges. These products target patients with dental problems and require dental surgical procedures to amend.

 b. Removable Prosthetic devices such as removable dentures.

               c. Other Devices such as orthodontic devices, sports guards and anti-snoring devices; also, raw materials, dental equipment and services etc.

 In terms of revenue return, fixed prosthetic devices as well as removable dentures are the major contributors to the Company. The graphs below illustrate the Company’s revenue mix as well as sales volume breakdown:

Source: Modern Dental 2018 interim report

SWOT ANALYSIS:

Strength :

  1. As dental healthcare importance increase, the company is able to capture the market share in dental prosthetic market through horizontal integrations.

Weakness :

  1. Niche market Barrier to entry may not be high.

 

Opportunities :

  1. Dental service in Asian market is growing, especially with aging population. The demand for dental prosthetic device increase.

 

Threat :

  1. Worldwide economic slowdown. Trade war.

 

「注:本人倪国权为证监会持牌人士。截至本评论文章发表日止,本人及/或其有联系者并无持有全部提及之证券的所有相关财务权益。」; Or
” I, Ni Kwok Kuen Alex, am a licensed person under the Securities and Futures Commission. Until the date this commentary was published, neither I and/or my affiliates are the beneficiary of the securities mentioned herein or are entitled to any financial interests in relation thereto. “

 

 

 

 

研究报告由辉立证券集团旗下于香港证监会持牌的辉立证券(香港)有限公司及/或辉立商品有限公司(「辉立」)所发报。本文所包含的资料均为辉立从相信为准确的来源搜集。辉立对有关报告所引致之任何损失或亏损概不负责。本报告所载的资料只供参考用途,并没有法律约束力,亦不构成投资建议,邀约,购入,出售任何产品。
投资涉及风险,有可能损失投资本金。你应该咨询专业人士,就本身的投资经验,财务状况,个人目标及风险取向,以提供投资意见。各类产品的风立,请参阅本公司网页http://www.phillip.com.hk「风险披露声明」。
辉立(或其雇员)可能持有本文所述有关的投资产品。此外,辉立(或任何附属公司)随时可能替向报告内容所述及的公司提供服务,招揽或业务往来。
以上资料为辉立拥有并受版权及知识产法保护。除非事先得到辉立明确书面批准,否则不应复制,散播或发布。
返回页首
联络我们
请即联络你的客户主任或致电我们。
研究部
电话 : (852) 2277 6846
传真 : (852) 2277 6565
电邮 : businessenquiry@phillip.com.hk

查询及支援
分行资料
投诉程序
查数网
登入
黄师傅每日讲股
研究部快讯
免费订阅
联络我们